Priced highly without insurance, semaglutide becomes affordable through insurance and savings programs
The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations
For maximum support, take as directed every day
As expected, both patient groups had substantially higher ratings of fatigue than controls on Chalder Fatigue Scale (ChFS) (Table 1)
Zeng P, Li S, Zheng YH, Liu FY, Wang JL, Zhang DL, Wei J
